Anders Aneman
Sydney WAHS · Liverpool Hospital, South Western Sydney Local Health District
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Anders Aneman as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 04:32 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT05540834 · Viscoelastic Testing Guided Tissue Plasminogen Activator Treatment in Acute Respiratory FailureSouth West Sydney Local Health District · recruiting · Acute Respiratory Failure, Hypercoagulability, Fibrinolysis Shutdown · principal investigator
- N/ANCT02841943 · Fluid Responsiveness After CArdiac Surgery StudySouth West Sydney Local Health District · completed · Critically Ill, Hypovolemia · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 04:32 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 04:32 UTC. The ranking covers the 200 most relevant of 33 PubMed records, and a shared surname and initials can bring in a namesake. All 33 on PubMed
- Targeted temperature management at 33°C versus 36°C after cardiac arrest.N Engl J Med · 20132,225 citationsRCR 84.5
- Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis.N Engl J Med · 20121,253 citationsRCR 49.1
- Lower versus higher hemoglobin threshold for transfusion in septic shock.N Engl J Med · 2014642 citationsRCR 25.2
- 332 citationsRCR 15.9
- Neuron-Specific Enolase as a Predictor of Death or Poor Neurological Outcome After Out-of-Hospital Cardiac Arrest and Targeted Temperature Management at 33°C and 36°C.J Am Coll Cardiol · 2015269 citationsRCR 11.5
- Target Temperature Management after out-of-hospital cardiac arrest--a randomized, parallel-group, assessor-blinded clinical trial--rationale and design.Am Heart J · 2012148 citationsRCR 5.2
- 146 citationsRCR 6.4
- Predictive value of interleukin-6 in post-cardiac arrest patients treated with targeted temperature management at 33 °C or 36 °C.Resuscitation · 201681 citationsRCR 3.2
- Prognostic significance of clinical seizures after cardiac arrest and target temperature management.Resuscitation · 201771 citationsRCR 3.3
- Target temperature management of 33°C and 36°C in patients with out-of-hospital cardiac arrest with initial non-shockable rhythm - a TTM sub-study.Resuscitation · 201556 citationsRCR 2.2